C-reactive protein and cancer—diagnostic and therapeutic insights
Cancer disease describes any pathology involving uncontrolled cell growth. As cells
duplicate, they can remain localized in defined tissues, forming tumor masses and altering …
duplicate, they can remain localized in defined tissues, forming tumor masses and altering …
The predictive value of inflammation-related peripheral blood measurements in cancer staging and prognosis
In this review, we discuss the interaction between cancer and markers of inflammation (such
as levels of inflammatory cells and proteins) in the circulation, and the potential benefits of …
as levels of inflammatory cells and proteins) in the circulation, and the potential benefits of …
A novel systemic inflammation response index (SIRI) for predicting the survival of patients with pancreatic cancer after chemotherapy
Q Qi, L Zhuang, Y Shen, Y Geng, S Yu, H Chen, L Liu… - Cancer, 2016 - Wiley Online Library
BACKGROUND Predicting survival is uniquely difficult in patients with pancreatic cancer
who receive chemotherapy. The authors developed a systemic inflammation response index …
who receive chemotherapy. The authors developed a systemic inflammation response index …
The systemic-immune-inflammation index independently predicts survival and recurrence in resectable pancreatic cancer and its prognostic value depends on …
Objective: Our aim was to determine the prognostic significance of the systemic-immune-
inflammation index (SIII) in patients with resectable pancreatic cancer, using cancer-specific …
inflammation index (SIII) in patients with resectable pancreatic cancer, using cancer-specific …
Phytosome complex of curcumin as complementary therapy of advanced pancreatic cancer improves safety and efficacy of gemcitabine: Results of a prospective …
D Pastorelli, ASC Fabricio, P Giovanis… - Pharmacological …, 2018 - Elsevier
A large body of biomedical evidence indicates that activation of Nrf2 by curcumin increases
the nucleophilic tone and damps inflammation cumulatively supporting the malignant …
the nucleophilic tone and damps inflammation cumulatively supporting the malignant …
The role of neutrophil to lymphocyte ratio for the assessment of liver fibrosis and cirrhosis: a systematic review
Y Peng, Y Li, Y He, Q Wei, Q Xie, L Zhang… - Expert review of …, 2018 - Taylor & Francis
Introduction: Neutrophil to lymphocyte ratio (NLR) is widely used to assess inflammatory
diseases. We performed a systematic review to explore the prognostic role of NLR for the …
diseases. We performed a systematic review to explore the prognostic role of NLR for the …
The predictive potential of the baseline C-reactive protein levels for the efficiency of immune checkpoint inhibitors in cancer patients: a systematic review and meta …
CL Han, GX Meng, ZN Ding, ZR Dong… - Frontiers in …, 2022 - frontiersin.org
Background The relationship between baseline C-reactive protein (CRP) level and the
prognosis of cancer patients receiving immune checkpoint inhibitor (ICI) treatment remains …
prognosis of cancer patients receiving immune checkpoint inhibitor (ICI) treatment remains …
Combined C-reactive protein and novel inflammatory parameters as a predictor in cancer—what can we learn from the hematological experience?
Ø Bruserud, HH Aarstad, THA Tvedt - Cancers, 2020 - mdpi.com
The acute phase reaction is a systemic response to acute or chronic inflammation. The
serum level of C-reactive protein (CRP) is the only acute phase biomarker widely used in …
serum level of C-reactive protein (CRP) is the only acute phase biomarker widely used in …
Preoperative neutrophil-lymphocyte and lymphocyte-monocyte ratios reflect immune cell population rearrangement in resectable pancreatic cancer
M Sierzega, M Lenart, M Rutkowska, M Surman… - Annals of surgical …, 2017 - Springer
Background Neutrophil-lymphocyte ratio (NLR), platelet-lymphocyte ratio (PLR), and
lymphocyte-monocyte ratio (LMR) may serve as a simple index of the immune function. The …
lymphocyte-monocyte ratio (LMR) may serve as a simple index of the immune function. The …
Systemic immune-inflammation index and changes of neutrophil-lymphocyte ratio as prognostic biomarkers for patients with pancreatic cancer treated with immune …
J Shang, X Han, H Zha, H Tao, X Li, F Yuan… - Frontiers in …, 2021 - frontiersin.org
The efficacy of current treatment regimens for pancreatic cancer (PC) remains unsatisfactory.
In recent years, immune checkpoint blockade (ICB) therapy has shown promising anti-tumor …
In recent years, immune checkpoint blockade (ICB) therapy has shown promising anti-tumor …